Cadila Healthcare is currently trading at Rs. 476.00, up by 0.60 points or 0.13% from its previous closing of Rs. 475.40 on the BSE.
The scrip opened at Rs. 479.85 and has touched a high and low of Rs. 479.85 and Rs. 473.00 respectively. So far 161066 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 509.35 on 15-Jan-2021 and a 52 week low of Rs. 212.70 on 13-Mar-2020.
Last one week high and low of the scrip stood at Rs. 488.85 and Rs. 442.50 respectively. The current market cap of the company is Rs. 48822.28 crore.
The promoters holding in the company stood at 74.88%, while Institutions and Non-Institutions held 16.96% and 7.97% respectively.
Cadila Healthcare has reported a fall of 34.32% in its net profit at Rs 140.30 crore for the quarter ended December 31, 2020 as compared to Rs 213.60 crore for the same quarter in the previous year. However, total income of the company increased by 11.67% at Rs 1,943.80 crore for Q3FY21 as compared Rs 1,740.70 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 41% in its net profit at Rs 527.20 crore for the quarter ended December 31, 2020 as compared to Rs 373.90 crore for the same quarter in the previous year. Total income of the company increased by 4.51% at Rs 3,823.10 crore for Q3FY21 as compared Rs 3,658.20 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1508.50 |
Dr. Reddys Lab | 5996.45 |
Cipla | 1393.00 |
Zydus Lifesciences | 929.30 |
Lupin | 1590.10 |
View more.. |